Empiric antibiotic selection criteria for respiratory infections in pediatric practice

Pediatric Infectious Disease Journal

Volumn 16, Issue 3 SUPPL., 1997, Pages

  Pichichero, Michael E ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

antibiotic; Respiratory infections; selection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LORACARBEF; MACROLIDE; PEDIAZOLE; PENICILLIN G; PENICILLIN V; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DERMATITIS; DRUG CHOICE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; OTITIS MEDIA; PALATABILITY; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; SERUM SICKNESS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TONSILLITIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; EMPIRICISM; HUMANS; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; RESPIRATORY TRACT INFECTIONS; TASTE;

EID: 0030899423     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199703001-00007     Document Type: Conference Paper

References (38)

1. Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993;12:115-20.
2. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324:601-13.
3. Wallace RJ Jr, Steele LC, Brooks DL, et al. Ampicillin, tetracycline, and chlorampheniol resistant Haemophilus influenzas in adults with chronic lung disease: relationship of resistance to prior antimicrobial therapy. Am Rev Respir Dis 1988;137:695-9.
4. Ford KL, Mason EO Jr, Kaplan SL, Lambeth LB, Tillman J. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr 1991;119:941-4.
5. Jacoby GA. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 1994;18:951-7.
6. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
7. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
8. Faden H, Doern G, Wolf J, Blocker M. Antimicrobial susceptibility of nasopharyngeal isolates of potential pathogens recovered from infants before antibiotic therapy: implications for the management of otitis media. Pediatr Infect Dis J 1994;13:609-12.
9. Thornsberry C, Brown SD, Yee YC, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the United States and the effect on susceptibility to oral cephalosporins. Infect Med 1993;10(Suppl D):15-24.
10. Jorgensen JH, Howell AW, Maher LA, Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol 1992;29:109-14.
11. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J Infect Dis 1994;170:461-4.
12. Huovinen P, Sundström L, Swedberg G, Sköld O. Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 1995;39:279-89.
13. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992;15:99-105.
14. Sempere MA, Gómez J, Ruiz J. Resistance of Streptococcus pneumoniae to erythromycin in adults and children. J Antimicrob Chemother 1992;29:348-9.
15. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995;14:179-83.
16. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U. S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994;38:2419-25.
17. Pelton SI, Teele DW, Bolduc G, Wendell P, Earle R. Trimethoprim/sulfamethoxazole-resistant nontypable Haemophilus influenzae. Pediatr Infect Dis J 1991;10:873-4.
18. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
19. Doern GV. Does there exist a rational, objective in vitro basis for the management of selected infections of the respiratory tract? Infect Dis Clin Pract 1994;3:75-80.
20. Pichichero ME, Pichichero CL. Persistent acute otitis media: II. Antimicrobial treatment. Pediatr Infect Dis J 1995;14: 183-8.
21. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
22. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
23. Pichichero ME. Resistant respiratory pathogens and extended-spectrum antibiotics. Am Fam Physician 1995;52:1739-46.
24. Rosenfield RM. What to expect from medical treatment of otitis media. Pediatr Infect Dis J 1995;14:731-8.
25. Pichichero ME. Assessing the treatment alternatives for acute otitis media. Pediatr Infect Dis J 1994;13:S27-34.
26. Pichichero ME. Antimicrobials for the treatment of group A beta-hemolytic streptococcal pharyngitis. In: Tandon R, Reddy KS, Narula J, eds. Rheumatic fever. Cambridge, UK: Oxford University Press (in press).
27. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr 1992; 120:72-7.
28. Blumer JL, McLinn SE, Deabate CA, et al. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Pediatr Infect Dis J 1995;14:S115-20.
29. McLinn SE, McCarty JM, Perrotta R, et al. Multicenter controlled trial comparing ceftibuten with amoxicillin/ clavulanate in the empiric treatment of acute otitis media. Pediatr Infect Dis J 1995;14:S108-14.
30. Pichichero ME, McLinn SE, Gooch WM, et al. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J 1995;14:S102-7.
31. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study. Pediatr Infect Dis J 1985;4:358-61.
32. Sbarbaro JA. Strategies to improve compliance with therapy. Am J Med 1985;79(Suppl. 6A):34-7.
33. Cockburn J, Gibbert RW, Reid AL, Sanson-Fisher RW. Determinants of non-compliance with short term antibiotic regimens. Br Med J 1987;295:814-8.
34. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
35. Ruff ME, Schotik DA, Bass JW, Vincent JM. Antimicrobial drug suspensions: a blind comparison of taste of fourteen common pediatric drugs. Pediatr Infect Dis J 1991;10:30-3.
36. Demers DM, Schotik D, Bass JW. Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxim̀e, cefprozil and loracarbef. Pediatr Infect Dis J 1994;13:87-9.
37. Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J 1994;13:686-90.
38. Thriene RW. Güter geschmack: güte compliance. TW Pädiatrie 1994;7:410-1.